191 related articles for article (PubMed ID: 28407327)
1. Oncolytic viral therapy for pancreatic cancer.
Rahal A; Musher B
J Surg Oncol; 2017 Jul; 116(1):94-103. PubMed ID: 28407327
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer.
Huang F; Wang BR; Wu YQ; Wang FC; Zhang J; Wang YG
World J Gastroenterol; 2016 Sep; 22(35):7999-8009. PubMed ID: 27672294
[TBL] [Abstract][Full Text] [Related]
3. Myxoma virus is oncolytic for human pancreatic adenocarcinoma cells.
Woo Y; Kelly KJ; Stanford MM; Galanis C; Chun YS; Fong Y; McFadden G
Ann Surg Oncol; 2008 Aug; 15(8):2329-35. PubMed ID: 18454298
[TBL] [Abstract][Full Text] [Related]
4. The potential of oncolytic virus therapy for pancreatic cancer.
Kasuya H; Takeda S; Nomoto S; Nakao A
Cancer Gene Ther; 2005 Sep; 12(9):725-36. PubMed ID: 15818382
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic vaccinia virus in combination with radiation shows synergistic antitumor efficacy in pancreatic cancer.
Dai MH; Liu SL; Chen NG; Zhang TP; You L; Q Zhang F; Chou TC; Szalay AA; Fong Y; Zhao YP
Cancer Lett; 2014 Mar; 344(2):282-90. PubMed ID: 24321381
[TBL] [Abstract][Full Text] [Related]
6. Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8
Wei W; Tian L; Zheng X; Zhong L; Chen Y; Dong H; Zhang G; Wang S; Tong X
Oncoimmunology; 2024; 13(1):2322173. PubMed ID: 38419758
[TBL] [Abstract][Full Text] [Related]
7. Viral therapy for pancreatic cancer: tackle the bad guys with poison.
Xu C; Li H; Su C; Li Z
Cancer Lett; 2013 Jun; 333(1):1-8. PubMed ID: 23354590
[TBL] [Abstract][Full Text] [Related]
8. Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma.
Blair AB; Zheng L
Chin Clin Oncol; 2017 Jun; 6(3):31. PubMed ID: 28705008
[TBL] [Abstract][Full Text] [Related]
9. Poxvirus oncolytic virotherapy.
Torres-Domínguez LE; McFadden G
Expert Opin Biol Ther; 2019 Jun; 19(6):561-573. PubMed ID: 30919708
[TBL] [Abstract][Full Text] [Related]
10. Advances in oncolytic viral therapy.
Woo Y; Adusumilli PS; Fong Y
Curr Opin Investig Drugs; 2006 Jun; 7(6):549-59. PubMed ID: 16784026
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic vaccinia virus: from bedside to benchtop and back.
Thorne SH
Curr Opin Mol Ther; 2008 Aug; 10(4):387-92. PubMed ID: 18683104
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma.
Buijs P; van Nieuwkoop S; Vaes V; Fouchier R; van Eijck C; van den Hoogen B
Viruses; 2015 Jun; 7(6):2980-98. PubMed ID: 26110582
[TBL] [Abstract][Full Text] [Related]
13. Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
Bossow S; Grossardt C; Temme A; Leber MF; Sawall S; Rieber EP; Cattaneo R; von Kalle C; Ungerechts G
Cancer Gene Ther; 2011 Aug; 18(8):598-608. PubMed ID: 21701532
[TBL] [Abstract][Full Text] [Related]
14. Clinical development directions in oncolytic viral therapy.
Eager RM; Nemunaitis J
Cancer Gene Ther; 2011 May; 18(5):305-17. PubMed ID: 21436867
[TBL] [Abstract][Full Text] [Related]
15. The Promise of Gene Therapy for Pancreatic Cancer.
Vassaux G; Angelova A; Baril P; Midoux P; Rommelaere J; Cordelier P
Hum Gene Ther; 2016 Feb; 27(2):127-33. PubMed ID: 26603492
[TBL] [Abstract][Full Text] [Related]
16. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of VCN-01, an oncolytic adenovirus combining fiber HSG-binding domain replacement with RGD and hyaluronidase expression.
Rodríguez-García A; Giménez-Alejandre M; Rojas JJ; Moreno R; Bazan-Peregrino M; Cascalló M; Alemany R
Clin Cancer Res; 2015 Mar; 21(6):1406-18. PubMed ID: 25391696
[TBL] [Abstract][Full Text] [Related]
18. Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy.
Kasuya H; Nishiyama Y; Nomoto S; Goshima F; Takeda S; Watanabe I; Nomura N; Shikano T; Fujii T; Kanazumi N; Nakao A
Cancer Gene Ther; 2007 Jun; 14(6):533-42. PubMed ID: 17415379
[TBL] [Abstract][Full Text] [Related]
19. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
20. GMCSF-armed vaccinia virus induces an antitumor immune response.
Parviainen S; Ahonen M; Diaconu I; Kipar A; Siurala M; Vähä-Koskela M; Kanerva A; Cerullo V; Hemminki A
Int J Cancer; 2015 Mar; 136(5):1065-72. PubMed ID: 25042001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
